Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology

SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients with aortic stenosis.

GlobeNewsWire • 4 hours ago

Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance

Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compared to 11.1% in prior year period Non-GAAP operating margin* of 21.3%, compared to 19.7% in prior year period GAAP EPS $0.70, up 51% Non-GAAP EPS* $1.12, up 22% Cash flow from operations of $175.2 million year-to-date Free cash flow* generation of $129.5 million year-to-date † Comparisons above are calculated for the current quarter compared with the third quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.

GlobeNewsWire • 4 hours ago

Merit Medical (MMSI) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • an hour ago

Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates

Merit Medical (MMSI) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $0.92 per share a year ago.

Zacks Investment Research • 25 minutes ago

Conestoga Small Cap Composite Q3 2026 Portfolio Activity

The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return for the Russell 2000 Growth Index. Small Cap Composite top 5 leaders include Repligen, Merit Medical, Stevanato Group, Descartes Systems and Digi International. Small Cap Composite bottom 5 laggards include Mercury Systems, AAON, RBC Bearings, SPX Technologies and UL Solutions.

Seeking Alpha • Oct 27, 2026

Cancer Stocks to Consider as Oncology Innovation Accelerates

Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.

Zacks Investment Research • Oct 9, 2026

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

GlobeNewsWire • Oct 6, 2026

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.

Zacks Investment Research • Oct 6, 2026

HSIC or MMSI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Oct 6, 2026

5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.

Zacks Investment Research • Oct 1, 2026